Soft Tissue Market, By Product type ( Fixation Products (Interference Screws, suture anchors, and others) Tissue patch (Biological mesh, synthetic mesh), and Others), By Application (Breast reconstruction, Dental and Dural repair, Hernia repair, Orthopedic repair, Vaginal prolapse repair, Skin repair, Cardiovascular surgery, and Others), By End User (Hospital, Clinics, Ambulatory surgery centers, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2030

Soft Tissue Market accounted for US$ 3.9 billion in 2020 and is estimated to be US$ 7.9 billion by 2030 and is anticipated to register a CAGR of 7.3%.

Soft tissue injuries occur when there is trauma or overuse occurs to the muscles, tendons or the ligaments. The soft tissue injuries are mostly the result of sudden unexpected or uncontrolled movement like stepping awkwardly off a curb and rolling over your ankle. Further, the most common soft tissue injuries are ankle sprain, back strain, calf strain, golfers/Tennis elbow, and hamstring strain. The increasing incidence of injuries in the field of sports is attributed to the growth of soft tissue repair market. Further, the government funding for sports players for soft tissue repair also fosters the market. Moreover, increasing number of accidents is expected to boost the soft tissue repair market. For instance, in 2015, according to study conducted by US Department of Transportation the road accident incidents have been increased by 3.8%.

Growing number of patients suffering from sports-related injuries

Factors influencing the soft tissue market is growing of sport related injuries such as sprains, strains, contusions, bursitis and tendinitis. Growing awareness and impact of these injuries on athletes is expected to foster the market. According to the National Safety Council (NSC), in 2021 exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation. 

Further, increasing geriatric population overall the globe and their injuries is also expected to foster the global soft tissue market.

Soft tissue repair market is segmented on the basis of product type, application, end user and geography. On the basis of product type, the soft tissue repair has been segmented into Fixation Products (Interference Screws, suture anchors, and others) tissue patch (Biological mesh, synthetic mesh), and Others. On the basis of application, the soft tissue repair market is segmented into breast reconstruction, dental and dural repair, hernia repair, orthopedic repair, vaginal prolapse repair, skin repair, cardiovascular surgery, and others.  On the basis of end user, the lobal soft tissue repair has been segmented into hospital, clinics, ambulatory surgery centers, and others.

Regional Insights:

On the basis of region, the Soft Tissue Market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market overall the forecast period, due to significant healthcare expenditure, early availability of new technologies and increased research and development activities. Further, Asia Pacific is expected to exhibit highest CAGR overall the forecast period due to rising product launches, distribution agreements, acquisitions, alliances and presence of developing countries. 

Report Scope:

Soft Tissue Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • • U.S.
    • Canada

The key players operating in the Soft Tissue Market includes Life Cell Corporation, Organogenesis, Smith And Nephew, Johnson And Johnson, Covidien, Arthrex Inc, Integra Life Sciences Corporation, Stryker Medical Corporation, Wright Medical Technology, C. R. Bard, De Puy Synthes, and American Medical Systems.

• Life Cell Corporation*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Organogensis
• Smith and Nephew
• Johnson and Johnson
• Covidien
• Arthrex Inc  
• Integra Life Sciences Corporation  
• Stryker Medical Corporation
• Wright Medical Technology
• C.R. Brad
• DePuy SYNTHES
• American Medical Systems

 “*” marked represents similar segmentation in other categories in the respective section